Third Pole Therapeutics

Waltham, MA · Founded 2014 · Privately Held (backing)

Developer of a medical inhalation device designed to offer life-saving cardiopulmonary therapies. Third Pole Therapeutics is based in Waltham, MA and was founded in 2014. Its last reported valuation was $240 million in Mar 2025. It has raised $126 million.

Last reported valuation
$240.0M
Oct 2026
Priced at
—
Total raised
$125.8M
Last round
—

Who backs Third Pole Therapeutics?

11 investors
InvestorType
National Institutes of HealthOther
Johnson & Johnson Innovation - JLABSOther
Acorn Campus Taiwan—
Lung—
Michael Marsh—
National Heart—
Saturn Partners—
Small Business Innovation Research and Small Business Technology Transfer Programs—
Starpath Ventures—
Unorthodox Ventures—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Third Pole Therapeutics investors

11 investors are on record for Third Pole Therapeutics, including National Institutes of Health, Johnson & Johnson Innovation - JLABS, Acorn Campus Taiwan and Lung.

Free account
More of Third Pole Therapeutics with a free account
  • ·The complete investor list: 11 names
  • ·Watch Third Pole Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Third Pole Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View